The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mechanism of action and translation to the clinic of detalimogene voraplasmid (EG-70): A novel, investigational, non-viral immunotherapy for non-muscle-invasive bladder cancer (NMIBC).
 
Vikram Narayan
Consulting or Advisory Role - Ferring
Research Funding - Ferring (Inst); Merck (Inst); Photocure (Inst)
 
Yair Lotan
Stock and Other Ownership Interests - Phinomics, Vessi Medical, CAPs medical, Nanorobot, Uroviu, C2i Genomics
Consulting or Advisory Role - Nanorobotics, Photocure, Astra-Zeneca, Merck, Fergene, Abbvie, Nucleix, Ambu, Seattle Genetics, Hitachi, Ferring Research, verity pharmaceutics, virtuoso surgical, Stimit, Urogen, Vessi medical, CAPs medical, Xcures, BMS, Nonagen, Aura Biosciences, Inc.,
Research Funding - Urogen, Seagen
 
Marie-Line Goulet
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Shauna Dauphinee
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Daniel Veilleux
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Kristine Louis
Employment - enGene
Stock and Other Ownership Interests - enGene
 
David Lazure
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Sarah Stevenson
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Darius Bilimoria
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Fazmina Zamzameer
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Ximin Chen
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Sébastien Sublemontier
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Sahar Amirkhani
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Carlos Fleet
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Raj Pruthi
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Anthony Cheung
Employment - enGene
Stock and Other Ownership Interests - enGene
 
James Sullivan
Employment - enGene
Stock and Other Ownership Interests - enGene
 
Vignesh Packiam
Consulting or Advisory Role - Valar Labs
 
Ashish Kamat
Consulting or Advisory Role - Arquer Diagnostics; Asieris Pharmaceuticals; Aspira Women's Health (I); Astellas Pharma; AstraZeneca; CG Oncology; Cystotech; enGene; Ferring; Genentech; GlaxoSmithKline (I); ImmunityBio; Imvax; Janssen; Merck; Nonagen Bioscience; Pfizer; Seagen; Theralase; Valar Labs; Vivet Therapeutics
Research Funding - Arquer Diagnostics (Inst); enGene (Inst); FKD Therapies (Inst); Patient-Centered Outcomes Research Institute (PCORI) (Inst); Photocure (Inst); Seagen (Inst); SWOG (Inst)
Patents, Royalties, Other Intellectual Property - Patent: CyPRIT (Cytokine Predictors of Response to Intravesical Therapy) joint with UT MD Anderson Cancer Center
Other Relationship - Bladder Cancer Advocacy Network; European Urology Oncology; International Bladder Cancer Group (IBCG); Journal of Urology; UroToday